RECRUITING

Pilot Study for PET/MR Imaging of Covid-19

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The primary goal of this project is to study the feasibility of a prototype brain-dedicated PET insert for an MR scanner for simultaneous acquisition of PET/MR images of metabolism and perfusion in Covid-19 negative and positive/once positive subjects. This study serves as a pilot study for establishing an imaging protocol for combined PET and MR derived functional information as well as MRI acquired anatomical information.

Official Title

Pilot Study for Simultaneous PET-MR Imaging of Covid-19 Associated Neurological Complications Using a Brain Dedicated PET Insert

Quick Facts

Study Start:2022-07-01
Study Completion:2024-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04954248

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Whole body radiation dose in the last year of less than 5000 mrem determined via subject verbal history reporting
  2. 2. Must be at least 21 years of age
  3. 3. Deemed healthy to endure duration of imaging study as confirmed via study PI
  4. 4. Proof of COVID-19 viral or antibody testing within the timeframe of \>20 days but \<=180 days prior to scan.
  1. 1. History of non-MRI compatible surgeries, implants, or activities
  2. 2. Pregnant or nursing
  3. 3. History of allergic reactions to PET radiotracers (via patient verbal report and /or medical record review.

Contacts and Locations

Study Contact

Marcus Lou
CONTACT
4158163957
mlou002@stanford.edu

Study Locations (Sites)

Stanford University
Palo Alto, California, 94305
United States

Collaborators and Investigators

Sponsor: Stanford University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-07-01
Study Completion Date2024-08-31

Study Record Updates

Study Start Date2022-07-01
Study Completion Date2024-08-31

Terms related to this study

Additional Relevant MeSH Terms

  • Brain Diseases
  • Covid19